Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
66.60
-0.40 (-0.60%)
Nov 3, 2025, 1:23 PM CST
TPEX:4747 Market Cap
TPEX:4747 has a market cap or net worth of 3.01 billion as of October 31, 2025. Its market cap has decreased by -1.46% in one year.
Market Cap
3.01B
Enterprise Value
2.07B
Revenue
582.81M
Ranking
n/a
PE Ratio
37.14
Stock Price
66.60
Market Cap Chart
Since January 8, 2010, TPEX:4747's market cap has increased from 500.25M to 3.01B, an increase of 501.79%. That is a compound annual growth rate of 12.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 3.01B | -6.29% |
| Dec 31, 2024 | 3.21B | -12.10% |
| Dec 29, 2023 | 3.66B | 137.81% |
| Dec 30, 2022 | 1.54B | 46.08% |
| Dec 29, 2021 | 1.05B | -5.78% |
| Dec 31, 2020 | 1.12B | -4.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |